LKT Labs

Biochemicals for Life Science Research

PF-3845

Product ID P200000
Cas No. 1196109-52-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $129.60 In stock
25 mg $477.00 In stock
100 mg $1,335.50 In stock
Bulk Quote

Quicklinks

Description

PF-3845 is an inhibitor of fatty acid amide hydrolase (FAAH). PF-3845 shows anti-allodynic effects in mice stimulated with LPS. It generates this effect without displaying any cannabinolic effects, making it a target for inflammatory pain management. When PF-3845 is used in tandem with the monoacyglycerol lipase (MAGL) inhibitor JZL184, it lessens withdrawal effects from opioid-dependent mice and produces anti-nociceptive effects without cannabimimetic side effects. Studies of PF-3845 treatment for traumatic brain injury in mice showed that PF-3845 lessened impairments found in control mice.

Product Info

Cas No.

1196109-52-0
Purity

≥98%
Formula

C24H23F3N4O2
Formula Wt.

456.47
Chemical Name

N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide hydrate
IUPAC Name

N-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide
Synonym

PF3845
Solubility

DMSO (>45 mg/mL)
Appearance

White to off-white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

P200000 MSDS PDF
Info Sheet

P200000 Info Sheet PDF

References

Booker L, Kinsey SG, Abdullah RA et al. The fatty acid hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. Br J Pharmacol. 2012 Apr;165(8):2485-96. PMID: 21506952.

Ramesh D, Gamage TF, Vanuytsel T et al. Dual Inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. Neuropsychopharmacology. 2013 May;38(6):1039-49. PMID: 23303065

Tchantchou F, Tucker LB, Fu AH, et al. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology. 2014 Oct;85:427-39. PMID: 24937045

Ghosh S, Kinsey SG Liu QS et al. Full Fatty ACid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimemetic Side Effects in Mice. J Pharmacol Exp Ther. 2015 Aug;354(2):111-20. PMID25998048.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I2118

    Ifenprodil Hemitartrate

    NMDA NR1/NR2B antagonist.

    ≥98%
  • T3461

    Tiplaxtinin

    PAI-1 inhibitor.

    ≥98%
  • F3473

    Fisetin

    Flavonoid found in various plant sources; matri...

    ≥97%
  • T0106

    Xylosyltaxol

    Taxane found in species of Taxus; potential mic...

    ≥98%
  • B8275

    n-Butyric Acid

    Fatty acid found in dairy products; HDAC inhibi...

    ≥98%
  • G7340

    GSK-126

    EZH2 HMT inhibitor.

    ≥98%, ≥99%ee
  • C3214

    CID-797718

    Potential PKD binding agent.

    ≥99%
  • J3204

    E-JIB-04

    Jumonji histone demethylase inhibitor.

    ≥98%
  • O446185

    Oleuropein

    Bioactive compound from olive tree.

    ≥98%
  • N0069

    Naringin

    Flavanone glycoside found in citrus fruit; SERM...

    ≥97%
  • R0351

    Ramoplanin

    Peptide; peptidoglycan inhibitor.

    ≥90%
  • L1982

    Leupeptin Hemisulfate

    Protease inhibitor.

    ≥95%
  • R5974

    Rosuvastatin Calcium

    Statin; HMG-CoA reductase inhibitor, potential ...

    ≥98%
  • T3032

    Thienyldecyl Isothiocyanate

    Thienylbutyl ITC analog.

    ≥95%
  • P200091

    PF-07104091

    CDK2 inhibitor

    ≥98%
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%
  • F1854

    Fenticonazole Nitrate

    Imidazole; 14-α demethylase inhibitor, potenti...

    ≥98%
  • A5070

    Angiotensin Acetate

    Peptide, derivative of AT I, cleavage product o...

    ≥95%
  • R7680

    Recombinant M. Tuberculosis Antigen TB 38+6+10

    Tuberculosis antigen
  • C1613

    Cediranib

    VEGFR inhibitor.

    ≥98%